SCHEMBL22488596

SCHEMBL22488596

CCOC(=O)C(O)COc1ccc(-c2nc3ccccc3[nH]2)cc1OCC(O)C(=O)OCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.53
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
THRB P10828 3/20 0.48
HPSE Q9Y251 1/20 0.48
MAPT P10636 7/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 3/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
POLB P06746 2/20 0.46
HTT P42858 1/20 0.46
HPGD P15428 2/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7399276 0.76 HPSE (0.54) AMY1AALDH1A1KDM4ETHRBHPSE
SCHEMBL24065356 0.76 MAPT (0.51) AMY1AALDH1A1KDM4ETHRBHPSE
SCHEMBL7391707 0.74 GUSB (0.71) ALDH1A1KDM4EHPSEMAPTKMT2A
SCHEMBL11253705 0.73 AMY1A (0.58) AMY1AALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL9261347 0.73 ALDH1A1 (0.74) ALDH1A1KDM4EHPSEMAPTKMT2A
SCHEMBL9009612 0.71 GUSB (0.47) AMY1AALDH1A1KDM4EHPSEMAPT
SCHEMBL9009625 0.71 AMY1A (0.52) AMY1AALDH1A1KDM4EHPSEMAPT
SCHEMBL12470605 0.70 ALOX5 (0.70) AMY1AALDH1A1KDM4EHPSEMAPT
SCHEMBL22488597 0.70 KDM4E (0.61) AMY1AALDH1A1KDM4ETHRBHPSE
SCHEMBL6520239 0.69 PDE4A (0.67) AMY1AALDH1A1KDM4ETHRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210373438-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2021-12-02 US disclosed
WO-2020195588-A1 ACTINIC-LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC-LIGHT-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERNING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE 富士フイルム株式会社 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210373438-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE RARA, RXRA, RAD54L AMY1A 450/4885ALDH1A1 1350/4885KDM4E 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.